Brad Screnci
About Brad Screnci
Brad Screnci is a Product Manager and Business Development Associate at Integral Molecular, where he focuses on managing antibody discovery platforms. He has a diverse background in research and business development, with experience in various roles across the mortgage and biotherapeutics industries.
Current Role at Integral Molecular
Brad Screnci serves as a Product Manager and Business Development Associate at Integral Molecular, a position he has held since 2021. In this role, he focuses on managing the growth of an antibody discovery platform. His work enables partners to accelerate the discovery and development of therapeutics that target membrane proteins. He has also managed multiple antibody discovery campaigns, which have led to intellectual property filings and a licensing partnership.
Previous Experience in Biotech and Finance
Prior to his current role, Brad Screnci worked at Aro Biotherapeutics as an Associate Scientist from 2020 to 2021. There, he supported the development of a therapeutic candidate pipeline based on alternative scaffold proteins called Centyrins. He also has extensive experience in the mortgage industry, having held various positions at PHH Mortgage, including Collateral Risk Analyst, Credit Risk Specialist, and Underwriter.
Academic Background
Brad Screnci earned a Master's Degree in Bioscience Technologies from Thomas Jefferson University, where he studied from 2013 to 2014. He also holds a Bachelor of Arts degree from Rutgers University, where he studied in the School of Communication, Information & Library Studies from 1997 to 2001. Additionally, he attended Holy Cross High School from 1993 to 1997.
Teaching Experience
Since 2016, Brad Screnci has been an Adjunct Professor at Rowan College at Burlington County. His teaching role has spanned eight years, during which he has contributed to the education of students in Mount Laurel, NJ. This position complements his extensive background in both research and industry.
Research and Development Contributions
Throughout his career, Brad Screnci has contributed to various research and development initiatives. At Integral Molecular, he has played a key role in managing antibody discovery campaigns. His previous research experience includes working as a Research Specialist at the University of Pennsylvania and as a Student Research Assistant at Thomas Jefferson University, where he was involved in cancer-related research.